Lactate and base deficit are predictors of mortality in critically ill patients with cancer (2011)
- Authors:
- USP affiliated authors: HOFF, PAULO MARCELO GEHM - FM ; AULER JUNIOR, JOSE OTAVIO COSTA - FM
- School: FM
- DOI: 10.1590/S1807-59322011001200007
- Subjects: CHOQUE SÉPTICO (COMPLICAÇÕES); FATORES DE RISCO; CUIDADOS CRÍTICOS; CUIDADOS PALIATIVOS; SEPSE (DIAGNÓSTICO;MORTALIDADE;COMPLICAÇÕES); MORTALIDADE HOSPITALAR; PROGNÓSTICO
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
HAJJAR, Ludhmila Abrahão et al. Lactate and base deficit are predictors of mortality in critically ill patients with cancer. Clinics, v. 66, n. 12 p. 2037-2042 2011, 2011Tradução . . Disponível em: http://www.scielo.br/pdf/clin/v66n12/a07v66n12.pdf. Acesso em: 28 jun. 2022. -
APA
Hajjar, L. A., Nakamura, R. E., Almeida, J. P. de, Fukushima, J. T., Hoff, P. M. G., Vincent, J. -L., et al. (2011). Lactate and base deficit are predictors of mortality in critically ill patients with cancer. Clinics, 66( 12 p. 2037-2042 2011). doi:10.1590/S1807-59322011001200007 -
NLM
Hajjar LA, Nakamura RE, Almeida JP de, Fukushima JT, Hoff PMG, Vincent J-L, Auler Júnior JOC, Galas FRBG. Lactate and base deficit are predictors of mortality in critically ill patients with cancer [Internet]. Clinics. 2011 ; 66( 12 p. 2037-2042 2011):[citado 2022 jun. 28 ] Available from: http://www.scielo.br/pdf/clin/v66n12/a07v66n12.pdf -
Vancouver
Hajjar LA, Nakamura RE, Almeida JP de, Fukushima JT, Hoff PMG, Vincent J-L, Auler Júnior JOC, Galas FRBG. Lactate and base deficit are predictors of mortality in critically ill patients with cancer [Internet]. Clinics. 2011 ; 66( 12 p. 2037-2042 2011):[citado 2022 jun. 28 ] Available from: http://www.scielo.br/pdf/clin/v66n12/a07v66n12.pdf - Outcomes of 3,400 patients with cancer admitted to intensive care unit: a Brazilian prospective study
- TSC2 rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias
- Pre-treatment neutrophil-to-lymphocyte ratio affects survival in patients with advanced hepatocellular carcinoma treated with sorafenib
- Do we need another antiangiogenesis agent for colorectal cancer: are bevacizumab and aflibercept the same?
- Building research capacity and clinical trials in developing countries
- Living better or living longer? perceptions of patients (PTS) and health care professionals (HCP) in ONCOLOGY
- Phase I and pharmacokinetic study of 3'-C-ethynylcytidine (TAS-106), an inhibitor of RNA polymerase I, II and III, in patients with advanced solid malignancies
- Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury
- Antiangiogenic Drugs for Colorectal Cancer: Exploring New Possibilities
- Análise restrospectiva de desfechos clínicos e fatores prognósticos em pacientes com carcinomatose meníngea
Informações sobre o DOI: 10.1590/S1807-59322011001200007 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
